TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - PFIZER INC Share Price

Certificat

DE000SF7UDM4

Delayed Deutsche Boerse AG 14:59:49 23/05/2024 BST
2.76 EUR +1.47% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - PFIZER INC
Current month-13.92%
1 month-11.97%
Date Price Change
23/05/24 2.76 +1.47%
22/05/24 2.72 -2.51%
21/05/24 2.79 -0.36%
20/05/24 2.8 +0.36%
17/05/24 2.79 +1.09%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 02:59 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SF7UDM
ISINDE000SF7UDM4
Date issued 17/08/2021
Strike 58.91 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.34
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 3.2
Lowest since issue 0.27
Spread 0.01
Spread %0.37%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
29.6 USD
Average target price
31.94 USD
Spread / Average Target
+7.90%
Consensus